{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:41:47Z","timestamp":1790764907752,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":848,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Baylor College of Medicine Pediatric Pilot Award","award":["49106-I"],"award-info":[{"award-number":["49106-I"]}]},{"name":"Mary R. Gibson Foundation","award":["Private"],"award-info":[{"award-number":["Private"]}]},{"name":"Mabel and Everett Hinkson Memorial Fund","award":["Private"],"award-info":[{"award-number":["Private"]}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1074\/jbc.ra118.002639","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T19:40:13Z","timestamp":1521488413000},"page":"7195-7208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells"],"prefix":"10.1016","volume":"293","author":[{"given":"Sarah E.","family":"Sartain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L.","family":"Moake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.002639_bib1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int"},{"key":"10.1074\/jbc.RA118.002639_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA118.002639_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejim.2013.05.009","article-title":"Complement activation in diseases presenting with thrombotic microangiopathy","volume":"24","author":"Meri","year":"2013","journal-title":"Eur. J. Intern Med"},{"key":"10.1074\/jbc.RA118.002639_bib4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood-2015-06-640995","article-title":"Complement in hemolytic anemia","volume":"126","author":"Brodsky","year":"2015","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.002639_bib5","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.002639_bib6","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.002639_bib7","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1073\/pnas.74.7.2701","article-title":"Interaction between the third complement protein and cell surface macromolecules","volume":"74","author":"Law","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"Suppl. 8","key":"10.1074\/jbc.RA118.002639_bib8","doi-asserted-by":"crossref","first-page":"l15","DOI":"10.1016\/j.vaccine.2008.11.023","article-title":"Discrimination between host and pathogens by the complement system","volume":"26","author":"Pangburn","year":"2008","journal-title":"Vaccine"},{"key":"10.1074\/jbc.RA118.002639_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pro.5560060201","article-title":"The internal thioester and the covalent binding properties of the complement proteins C3 and C4","volume":"6","author":"Law","year":"1997","journal-title":"Protein Sci"},{"key":"10.1074\/jbc.RA118.002639_bib10","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1073\/pnas.75.8.3948","article-title":"Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins","volume":"75","author":"Schreiber","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002639_bib11","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.166.4.2635","article-title":"Formation of high-affinity C5 convertases of the alternative pathway of complement","volume":"166","author":"Rawal","year":"2001","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1084\/jem.138.6.1305","article-title":"Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement","volume":"138","author":"Fearon","year":"1973","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA118.002639_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.120.3112.279","article-title":"The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena","volume":"120","author":"Pillemer","year":"1954","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.002639_bib14","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1073\/pnas.73.9.3268","article-title":"Control of the amplification convertase of complement by the plasma protein \u03b21H","volume":"73","author":"Weiler","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002639_bib15","first-page":"139","article-title":"Activation of complement via the alternative pathway","volume":"42","author":"Pangburn","year":"1983","journal-title":"Fed. Proc"},{"key":"10.1074\/jbc.RA118.002639_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF01893018","article-title":"Initiation of complement activation","volume":"7","author":"Lachmann","year":"1984","journal-title":"Springer Semin. Immunopathol"},{"key":"10.1074\/jbc.RA118.002639_bib17","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.4049\/jimmunol.141.11.3895","article-title":"C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme","volume":"141","author":"Kinoshita","year":"1988","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib18","doi-asserted-by":"crossref","first-page":"e59372","DOI":"10.1371\/journal.pone.0059372","article-title":"Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA118.002639_bib19","doi-asserted-by":"crossref","first-page":"e73715","DOI":"10.1371\/journal.pone.0073715","article-title":"The interaction between factor H and Von Willebrand factor","volume":"8","author":"Feng","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA118.002639_bib20","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.1301221","article-title":"Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy","volume":"191","author":"Tati","year":"2013","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.002639_bib22","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib23","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.4049\/jimmunol.1302787","article-title":"The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis","volume":"193","author":"Mueller-Ortiz","year":"2014","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib24","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.4049\/jimmunol.1601420","article-title":"The complement anaphylatoxins C5a and C3a suppress IFN-\u03b2 production in response to Listeria monocytogenes by inhibition of the cyclic dinucleotide-activated cytosolic surveillance pathway","volume":"198","author":"Mueller-Ortiz","year":"2017","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2014.12.002","article-title":"Expression of anaphylatoxin receptors on platelets in patients with coronary heart disease","volume":"238","author":"Patzelt","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1074\/jbc.RA118.002639_bib26","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.169.4.2102","article-title":"Complement c3a and c5a induce different signal transduction cascades in endothelial cells","volume":"169","author":"Schraufstatter","year":"2002","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4049\/jimmunol.122.1.75","article-title":"Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and \u03b21H for cell-bound C3b","volume":"122","author":"Kazatchkine","year":"1979","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib28","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.144.5.1147","article-title":"Modulation of the alternative complement pathways by \u03b21H globulin","volume":"144","author":"Whaley","year":"1976","journal-title":"J. Exp. Med"},{"key":"10.1074\/jbc.RA118.002639_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0161-5890(80)90119-4","article-title":"The physiological breakdown of the third component of human complement","volume":"17","author":"Harrison","year":"1980","journal-title":"Mol. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA118.002639_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.iy.09.040191.002243","article-title":"Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster","volume":"9","author":"Liszewski","year":"1991","journal-title":"Annu. Rev. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4049\/jimmunol.129.1.184","article-title":"Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system","volume":"129","author":"Nicholson-Weller","year":"1982","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib33","doi-asserted-by":"crossref","first-page":"10212","DOI":"10.1073\/pnas.93.19.10212","article-title":"The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex","volume":"93","author":"Stearns-Kurosawa","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002639_bib34","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum. Mutat"},{"key":"10.1074\/jbc.RA118.002639_bib35","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1074\/jbc.RA118.002639_bib36","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.002639_bib37","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002639_bib38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.002639_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ajh.20648","article-title":"Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Nakamae","year":"2006","journal-title":"Am. J. Hematol"},{"key":"10.1074\/jbc.RA118.002639_bib40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/bmt.2009.230","article-title":"Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning","volume":"45","author":"Willems","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1074\/jbc.RA118.002639_bib41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"key":"10.1074\/jbc.RA118.002639_bib42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bbmt.2005.07.012","article-title":"Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children","volume":"11","author":"Hale","year":"2005","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1074\/jbc.RA118.002639_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","article-title":"ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy","volume":"36","author":"Worel","year":"2007","journal-title":"Transfus. Apher. Sci"},{"key":"10.1074\/jbc.RA118.002639_bib44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1074\/jbc.RA118.002639_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/pbc.22861","article-title":"Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus","volume":"57","author":"Rosenthal","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1074\/jbc.RA118.002639_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA118.002639_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J. Rare Dis"},{"key":"10.1074\/jbc.RA118.002639_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"10.1074\/jbc.RA118.002639_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","article-title":"Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study","volume":"85","author":"Siami","year":"2008","journal-title":"Transplantation"},{"key":"10.1074\/jbc.RA118.002639_bib50","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA118.002639_bib51","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","article-title":"Complement and the atypical hemolytic uremic syndrome in children","volume":"23","author":"Loirat","year":"2008","journal-title":"Pediatr. Nephrol"},{"key":"10.1074\/jbc.RA118.002639_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.ajkd.2013.07.011","article-title":"Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases","volume":"63","author":"Fakhouri","year":"2014","journal-title":"Am. J. Kidney Dis"},{"key":"10.1074\/jbc.RA118.002639_bib53","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","article-title":"Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS","volume":"125","author":"Cofiell","year":"2015","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.002639_bib54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0049-3848(92)90286-J","article-title":"Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor \u03b1 (TNF\u03b1)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT)","volume":"66","author":"Seeber","year":"1992","journal-title":"Thromb. Res"},{"key":"10.1074\/jbc.RA118.002639_bib55","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4049\/jimmunol.1500960","article-title":"TNF regulates essential alternative complement pathway components and impairs activation of protein C in human glomerular endothelial cells","volume":"196","author":"Sartain","year":"2016","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib56","doi-asserted-by":"crossref","first-page":"14311","DOI":"10.1074\/jbc.M115.710350","article-title":"Characterization of the regulation of CD46 RNA alternative splicing","volume":"291","author":"Tang","year":"2016","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002639_bib57","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.4049\/jimmunol.136.6.2216","article-title":"Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases","volume":"136","author":"Pangburn","year":"1986","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib58","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.4049\/jimmunol.162.12.7409","article-title":"Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a","volume":"162","author":"Settmacher","year":"1999","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib59","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/eji.200323293","article-title":"Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signaling","volume":"33","author":"Settmacher","year":"2003","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj2640581","article-title":"Functional properties of membrane cofactor protein of complement","volume":"264","author":"Seya","year":"1989","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.RA118.002639_bib61","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1042\/bst0301006","article-title":"Structure and function of complement C5 convertase enzymes","volume":"30","author":"Pangburn","year":"2002","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/jbc.RA118.002639_bib62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archsurg.1988.01400290131023","article-title":"Anaphylatoxin formation in sepsis","volume":"123","author":"Bengtson","year":"1988","journal-title":"Arch. Surg"},{"key":"10.1074\/jbc.RA118.002639_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9343(89)90224-6","article-title":"Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis","volume":"86","author":"Hack","year":"1989","journal-title":"Am. J. Med"},{"key":"10.1074\/jbc.RA118.002639_bib64","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1097\/00003246-200008000-00019","article-title":"Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6","volume":"28","author":"Selberg","year":"2000","journal-title":"Crit. Care Med"},{"key":"10.1074\/jbc.RA118.002639_bib65","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI26582","article-title":"A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma","volume":"116","author":"K\u00f6hl","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA118.002639_bib66","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.4049\/jimmunol.169.10.5926","article-title":"Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy","volume":"169","author":"Drouin","year":"2002","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib67","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.4049\/jimmunol.165.10.5401","article-title":"Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma","volume":"165","author":"Bautsch","year":"2000","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"Ji","year":"2002","journal-title":"Immunity"},{"key":"10.1074\/jbc.RA118.002639_bib69","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1074-7613(02)00327-8","article-title":"Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo","volume":"16","author":"Trcka","year":"2002","journal-title":"Immunity"},{"key":"10.1074\/jbc.RA118.002639_bib70","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1172\/JCI25536","article-title":"Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice","volume":"116","author":"Kumar","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA118.002639_bib71","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by \u03b2-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"Suppl. 1","key":"10.1074\/jbc.RA118.002639_bib72","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord"},{"key":"10.1074\/jbc.RA118.002639_bib73","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol"},{"key":"10.1074\/jbc.RA118.002639_bib74","doi-asserted-by":"crossref","first-page":"e113639","DOI":"10.1371\/journal.pone.0113639","article-title":"C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-\u03b2\/smad3 and IKB\u03b1 pathway","volume":"9","author":"Li","year":"2014","journal-title":"PLoS one"},{"key":"10.1074\/jbc.RA118.002639_bib75","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.175.3.1947","article-title":"Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis","volume":"175","author":"Bao","year":"2005","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10875-013-9970-6","article-title":"C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy","volume":"34","author":"Liu","year":"2014","journal-title":"J. Clin. Immunol"},{"key":"10.1074\/jbc.RA118.002639_bib77","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2011111072","article-title":"C3a and C5a promote renal ischemia-reperfusion injury","volume":"23","author":"Peng","year":"2012","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA118.002639_bib78","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.RA118.002639_bib79","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212\u0394\u0394CT) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1074\/jbc.RA118.002639_bib80","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem"},{"key":"10.1074\/jbc.RA118.002639_bib81","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1073\/pnas.78.4.2249","article-title":"Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C","volume":"78","author":"Esmon","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582039205X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582039205X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.002639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T17:49:30Z","timestamp":1693590570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582039205X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":81,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S002192582039205X"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.002639","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.002639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sartain et al.","name":"copyright","label":"Copyright"}]}}